BlackRock Inc. cut its stake in Imperva Inc (NASDAQ:IMPV) by 15.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,271,197 shares of the software maker’s stock after selling 425,612 shares during the period. BlackRock Inc. owned 6.52% of Imperva worth $98,342,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in IMPV. Schwab Charles Investment Management Inc. boosted its holdings in Imperva by 12.6% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 156,057 shares of the software maker’s stock valued at $6,196,000 after acquiring an additional 17,453 shares during the last quarter. Teacher Retirement System of Texas bought a new stake in Imperva in the fourth quarter valued at approximately $394,000. Sei Investments Co. boosted its holdings in Imperva by 196,449.0% in the fourth quarter. Sei Investments Co. now owns 96,309 shares of the software maker’s stock valued at $3,824,000 after acquiring an additional 96,260 shares during the last quarter. UBS Asset Management Americas Inc. boosted its holdings in Imperva by 21.4% in the fourth quarter. UBS Asset Management Americas Inc. now owns 15,301 shares of the software maker’s stock valued at $607,000 after acquiring an additional 2,700 shares during the last quarter. Finally, Quadrature Capital Ltd bought a new stake in Imperva in the fourth quarter valued at approximately $224,000.
Shares of Imperva opened at $48.25 on Friday, according to MarketBeat. Imperva Inc has a 52-week low of $37.17 and a 52-week high of $53.95. The company has a market capitalization of $1.64 billion, a price-to-earnings ratio of -172.32 and a beta of 1.69.
Imperva (NASDAQ:IMPV) last issued its quarterly earnings results on Thursday, April 26th. The software maker reported $0.26 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.19 by $0.07. Imperva had a negative return on equity of 1.63% and a negative net margin of 3.00%. The firm had revenue of $84.24 million for the quarter, compared to analyst estimates of $83.77 million. During the same period in the previous year, the firm earned $0.09 earnings per share. The company’s revenue was up 16.5% compared to the same quarter last year. equities research analysts anticipate that Imperva Inc will post -0.61 EPS for the current year.
Several brokerages recently commented on IMPV. BidaskClub cut Imperva from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 23rd. Oppenheimer upped their target price on Imperva from $55.00 to $60.00 and gave the company an “outperform” rating in a report on Monday, June 18th. Stephens upped their target price on Imperva from $61.00 to $67.00 and gave the company an “overweight” rating in a report on Thursday, June 14th. ValuEngine upgraded Imperva from a “sell” rating to a “hold” rating in a report on Saturday, June 2nd. Finally, BTIG Research reiterated a “hold” rating on shares of Imperva in a report on Sunday, April 29th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and nine have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $53.42.
Imperva Company Profile
Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.